Physician profile
Amanda D Underwood
NPI 1942724414
$5,587.96
in general payments reported to CMS, 2019-2025
8 companies · $1,585 in 2025
The $1,585 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $315 · 2022: $199 · 2023: $2,089 · 2024: $1,400 · 2025: $1,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,073.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,386.09 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $1,838.95 | 2021-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Abbott Laboratories | $548.61 | 2021-2025 | Amplatzer Amulet, Mitraclip |
| Boston Scientific Corporation | $402.90 | 2021-2025 | Watchman Flx, Sentinel, Versacross Access Solution |
| Medtronic, INC. | $233.63 | 2021 | |
| Angiodynamics, INC. | $122.25 | 2024 | Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.41 | 2023 | Lifevest |
| Olympus America INC. | $19.12 | 2025 | Evis Exera III Colonovideoscope, Gastrointestinal Videoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Underwood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.